Related Experiment Video
Updated: Jul 19, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
Acute transient encephalopathy following paclitaxel treatment in an adolescent with a recurrent suprasellar germinoma
James Rook1, Tena Rosser, Jason Fangusaro
1Department of Pediatrics, Loma Linda University Children's Hospital, Loma Linda University School of Medicine, Loma Linda, California, USA.
Abstract:
Paclitaxel is an antineoplastic agent that is used in the treatment of a variety of solid tumors. Dose-limiting side effects of myelosuppression and peripheral neuropathy are well known. Paclitaxel has minimal penetration of the blood-brain barrier and central nervous system side effects are rare. However, transient encephalopathy following paclitaxel infusion has been described in adults but not in children. We present the case of a 14-year-old female with a recurrent suprasellar germinoma who developed an acute encephalopathy 4-6 hr following paclitaxel infusion.
Related Concept Videos
Encephalitis l: Introduction
Brain Abscess l: Introduction

